Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management.
about
Dipeptidyl-peptidase (DPP)-4 inhibitors or glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitusAntidiabetic treatment with gliptins: focus on cardiovascular effects and outcomesIncretin-based therapies in prediabetes: Current evidence and future perspectivesA novel glucagon-like peptide 1 peptide identified from Ophisaurus harti.Efficacy of initial Basal-supported oral therapy with sitagliptin in untreated type 2 diabetes.Cinnamic Acid and Its Derivatives: Mechanisms for Prevention and Management of Diabetes and Its Complications.Liraglutide: clinical pharmacology and considerations for therapy.Melatonin and the skeleton.Taurine May Modulate Bone in Cholesterol Fed Estrogen Deficiency-Induced Rats.New α-glucosidase inhibitors from marine algae-derived Streptomyces sp. OUCMDZ-3434.The prevalence and risk factors for osteoporosis among 18- to 49-year-old Turkish women.A role for PYY3-36 in GLP1-induced insulin secretion.High bone mineral density is associated with high body mass index.High weight or body mass index increase the risk of vertebral fractures in postmenopausal osteoporotic women.DPP-4 inhibitors and heart failure: a potential role for pharmacogenomics.Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment.Skeletal deterioration following ovarian failure: can some features be a direct consequence of estrogen loss while others are more related to physical inactivity?A Review of the Health Benefits of Cherries.
P2860
Q24185805-52F3DB47-8651-4967-B760-7F3B9F83E8B4Q26785454-37AC85F4-0233-4A8F-8476-47CE56F10390Q34699191-AD54AF31-249D-4F1B-B1FB-01FAD5370625Q34871648-1BF14876-C1C4-45C0-AA92-EE918A918EDFQ37468391-F9FBDA03-A5E4-40F7-8350-24C68FDD36D0Q37673273-56DB7CE7-6037-405D-BB27-A15210CA5301Q37933408-4D96C5A2-CFE6-46A2-94BF-9B24C723A1ECQ38110221-1DF3D1F8-5F42-4729-B66E-C6C3AE36DA74Q38399209-12B2E315-D1E0-4693-9E89-E648C495A0CCQ38798553-1910752A-5EB9-44A6-A0C1-3D45387AED84Q39324995-173BB28B-6FB6-44DE-BC0D-DAF31F4FCC49Q42619245-DE5FA3D1-8CF8-4189-B105-F37D4DFC3F09Q43672501-C112BCAC-A8ED-4548-9CEE-70A8A71B193FQ47177725-058AE894-EE88-4DAB-A5B0-4D24E20353C9Q48229830-D669F05C-917E-44EF-A90F-E73306037CA0Q50351054-267E0BEA-FC08-4AB1-AA33-654E001E1690Q51108068-A0E8F289-7EE2-475B-ACB8-226F47A7A8C6Q54964952-8FA3EF9A-32E1-4F66-8F2F-B2A8E8DD14A7
P2860
Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management.
@en
type
label
Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management.
@en
prefLabel
Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management.
@en
P2093
P2860
P356
P1476
Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management.
@en
P2093
Comaschi M
Crepaldi G
Del Prato S
Paolisso G
P2860
P2888
P304
P356
10.1007/BF03346357
P577
2007-07-01T00:00:00Z